codevelopment agreement
In New Deal, Oncocyte Gains Global Market Runway, Thermo Fisher Nabs Steward for Clinical Kits
Premium
Company leaders discussed details about the practical and financial benefits the deal provides both firms this week.
Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs
The companies are working together to bring to market in vitro diagnostic versions of Thermo Fisher's Oncomine Comprehensive Assay Plus and Oncocyte's DetermaIO test.
Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs
The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases.
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic
The two companies will codevelop the next-generation sequencing test for Kartos's MDM2 inhibitor, KRT-232, being studied in TP53 wild-type blood cancers.